NCT02020577View on ClinicalTrials.gov

Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2016

Conditions
Neoplasms
Interventions
DRUG

Cetuximab( erbitux®)

once per week

DRUG

Afatinib

once per day

Trial Locations (2)

Unknown

1200.122.33001 Boehringer Ingelheim Investigational Site, Villejuif

1200.122.34001 Boehringer Ingelheim Investigational Site, Madrid

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY